AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2356909 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental educational day care program
Number of subjects: 86
Study 2356909 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study 384024 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg. butorphanol
Number of subjects: 81
Study 384024 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg. butorphanol
Number of subjects: 81
Study 384024 — intervention group
Group type: COMPARATOR
Intervention: 80 mg. meperidine
Number of subjects: 81
Study 29463420 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KIN)
Number of subjects: 110
Study 29463420 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 110
Study 29463420 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraffin (PARA)
Number of subjects: 110
Study 28987237 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention
Number of subjects: 123
Study 28987237 — intervention group
Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 123
Study 25552526 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based respiratory muscle training with progressively increased resistance from 30% to 75% of each patient's maximum respiratory pressure, 6 times a week for 4 months
Number of subjects: 18
Study 25552526 — intervention group
Group type: COMPARATOR
Intervention: Control group used a fixed resistance of 9 centimeters of water, 6 times a week for 4 months
Number of subjects: 18
Study 25268437 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual ward
Number of subjects: 1923
Study 25268437 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1923
Study 22103436 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial monotherapy
Number of subjects: 497
Study 22103436 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy
Number of subjects: 497
Study 19467415 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue base radiofrequency reduction
Number of subjects: 57
Study 19467415 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue base suspension
Number of subjects: 57
Study 19467415 — intervention group
Group type: COMPARATOR
Intervention: Obese patients (tongue base radiofrequency reduction)
Number of subjects: 57
Study 19467415 — intervention group
Group type: COMPARATOR
Intervention: Obese patients (tongue base suspension)
Number of subjects: 57
Study 17612946 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 30 mg/day (bedtime dosing)
Number of subjects: 80
Study 17612946 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 60 mg/day (bedtime dosing)
Number of subjects: 80
Study 17612946 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (bedtime dosing)
Number of subjects: 80
Study 17612946 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine GITS 30 mg/day (morning dosing)
Number of subjects: 80
Study 15042461 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-myelography
Number of subjects: 1022
Study 15042461 — intervention group
Group type: COMPARATOR
Intervention: Conventional MR examination
Number of subjects: 1022
Study 11750840 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral topotecan, 2.3 mg/m(2)/day for 5 days every 21 days
Number of subjects: 266
Study 11750840 — intervention group
Group type: COMPARATOR
Intervention: Intravenous topotecan, 1.5 mg/m(2)/day for 5 days every 21 days
Number of subjects: 266
Study 9717776 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized information about colonoscopy plus additional sensory information describing what they could expect to feel (for information seekers)
Number of subjects: 80
Study 9717776 — intervention group
Group type: COMPARATOR
Intervention: Standardized information about colonoscopy (for information avoiders)
Number of subjects: 80
Study 9717776 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized information about colonoscopy congruent with coping style
Number of subjects: 80
Study 9717776 — intervention group
Group type: COMPARATOR
Intervention: Standardized information about colonoscopy not congruent with coping style
Number of subjects: 80
Study 8984044 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose PRP-T vaccine
Number of subjects: 125
Study 8984044 — intervention group
Group type: EXPERIMENTAL
Intervention: Associated with DPT vaccine
Number of subjects: 125
Study 2803579 — intervention group
Group type: EXPERIMENTAL
Intervention: sulbactam/ampicillin
Number of subjects: 36
Study 2803579 — intervention group
Group type: COMPARATOR
Intervention: clindamycin/gentamicin
Number of subjects: 36
Study 7448509 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiseptic skin preparation and daily care of the cannula site
Number of subjects: 50
Study 7448509 — intervention group
Group type: COMPARATOR
Intervention: No skin preparation before or after cannula insertion
Number of subjects: 50
Study 31873920 — intervention group
Group type: EXPERIMENTAL
Intervention: End of rotation evaluations
Number of subjects: 2
Study 31873920 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient care and medical knowledge competencies
Number of subjects: 2
Study 31873920 — intervention group
Group type: EXPERIMENTAL
Intervention: Systems-based practice and practice-based learning and improvement competencies
Number of subjects: 2
Study 31873920 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher number of available evaluations
Number of subjects: 2
Study 31873920 — intervention group
Group type: EXPERIMENTAL
Intervention: End of rotation evaluations and clinical skills examinations
Number of subjects: 2
Study 29635402 — intervention group
Group type: EXPERIMENTAL
Intervention: D+E (diet-induced weight loss and exercise)
Number of subjects: 454
Study 29635402 — intervention group
Group type: COMPARATOR
Intervention: D (diet-induced weight loss)
Number of subjects: 454
Study 29635402 — intervention group
Group type: COMPARATOR
Intervention: E (exercise)
Number of subjects: 454
Study 29635402 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 454
Study 25807867 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT complex
Number of subjects: 0
Study 25807867 — intervention group
Group type: COMPARATOR
Intervention: Emollient base
Number of subjects: 0
Study 23618743 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sacropexy
Number of subjects: 262
Study 23618743 — intervention group
Group type: COMPARATOR
Intervention: Vaginal mesh
Number of subjects: 262
Study 21372306 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 44
Study 21372306 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study 19538486 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg(+) grafts
Number of subjects: 373
Study 19538486 — intervention group
Group type: COMPARATOR
Intervention: HBsAg(-) grafts
Number of subjects: 373
Study 19248718 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio computer‐assisted self‐interview (ACASI)
Number of subjects: 0
Study 19248718 — intervention group
Group type: COMPARATOR
Intervention: Conventional face‐to‐face (FTF) interview
Number of subjects: 0
Study 15380117 — intervention group
Group type: EXPERIMENTAL
Intervention: Mozart's Sonata for Two Pianos (K448)
Number of subjects: 4
Study 15380117 — intervention group
Group type: COMPARATOR
Intervention: Control music (Beethoven's Für Elise)
Number of subjects: 4
Study 11682346 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 Hz CES
Number of subjects: 12
Study 11682346 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 Hz CES
Number of subjects: 12
Study 11682346 — intervention group
Group type: COMPARATOR
Intervention: Sham CES
Number of subjects: 12
Study 9709278 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammographic screening (invited between 1978 and 1990 for MMST II, and not invited until 1991-1994 for control group in MMST I)
Number of subjects: 25870
Study 9709278 — intervention group
Group type: COMPARATOR
Intervention: Control group (not invited for examination until four years after the code was broken in MMST I)
Number of subjects: 25870
Study 8325178 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (50 micrograms)
Number of subjects: 27
Study 8325178 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (500 micrograms)
Number of subjects: 27
Study 8325178 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (Control group)
Number of subjects: 27
Study 3539614 — intervention group
Group type: COMPARATOR
Intervention: Tiapamil 600 mg
Number of subjects: 10
Study 3539614 — intervention group
Group type: COMPARATOR
Intervention: Tiapamil 800 mg
Number of subjects: 10
Study 11213009 — intervention group
Group type: EXPERIMENTAL
Intervention: Two percent lignocaine gel
Number of subjects: 308
Study 11213009 — intervention group
Group type: COMPARATOR
Intervention: Inert gel (placebo)
Number of subjects: 308
Study 30679762 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic fasting glucose levels after PCa diagnosis
Number of subjects: 1770
Study 30679762 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic fasting glucose levels among participants with localized cancer at diagnosis
Number of subjects: 1770
Study 30679762 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose measurements taken up to 5 years earlier
Number of subjects: 1770
Study 30679762 — intervention group
Group type: COMPARATOR
Intervention: Diabetic glucose levels measured before the diagnosis
Number of subjects: 1770
Study 29191649 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine, 20 mL plus 1 μg/kg of dexmedetomidine (group RD)
Number of subjects: 60
Study 29191649 — intervention group
Group type: COMPARATOR
Intervention: 0.375% ropivacaine, 20 mL only (group R)
Number of subjects: 60
Study 27429977 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable knotless wound closure device
Number of subjects: 62
Study 27429977 — intervention group
Group type: COMPARATOR
Intervention: 2‐0 Vicryl suture
Number of subjects: 62
Study 25376714 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted self-reduction technique
Number of subjects: 237
Study 25376714 — intervention group
Group type: COMPARATOR
Intervention: Traction-countertraction method
Number of subjects: 237
Study 23294785 — intervention group
Group type: EXPERIMENTAL
Intervention: HumaPen Memoir
Number of subjects: 257
Study 23294785 — intervention group
Group type: COMPARATOR
Intervention: HumaPen Luxura
Number of subjects: 257
Study 21438413 — intervention group
Group type: EXPERIMENTAL
Intervention: Pingchuan water decoction (one tie per day, in four to six-divided doses for eight weeks)
Number of subjects: 0
Study 21438413 — intervention group
Group type: COMPARATOR
Intervention: Montelukast Sodium tablets (4 mg for 2-5 years old or 5 mg for 6-14 years old, once every night before sleeping for eight weeks)
Number of subjects: 0
Study 17682119 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine (500 mg orally three times daily for 2 weeks)
Number of subjects: 12
Study 17682119 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 mg orally three times daily for 2 weeks)
Number of subjects: 12
Study 16205353 — intervention group
Group type: EXPERIMENTAL
Intervention: Prodisc total disc arthroplasty
Number of subjects: 118
Study 12402261 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine cell implantation (DYS+ group)
Number of subjects: 17
Study 12402261 — intervention group
Group type: COMPARATOR
Intervention: Dopamine cell implantation (DYS- group)
Number of subjects: 17
Study 10426383 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-h hyperinsulinemia (30 mU x kg(‐1) x h(‐1))
Number of subjects: 16
Study 10426383 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-h Acipimox (250 mg/4 h)
Number of subjects: 16
Study 10426383 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-h hyperinsulinemia
Number of subjects: 16
Study 10426383 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-h Acipimox
Number of subjects: 16
Study 7770708 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole
Number of subjects: 279
Study 7770708 — intervention group
Group type: COMPARATOR
Intervention: 20 mg omeprazole
Number of subjects: 279
Study 2124986 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 micrograms plasma vaccine Pasteur (containing 1% pre-S2)
Number of subjects: 102
Study 2124986 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms plasma vaccine MSD (no pre-S2)
Number of subjects: 102
Study 2124986 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms Pasteur
Number of subjects: 102
Study 2124986 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 micrograms MSD
Number of subjects: 102
Study 6893754 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 28
Study 30412772 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printing
Number of subjects: 20
Study 30412772 — intervention group
Group type: COMPARATOR
Intervention: Control (no 3D printing)
Number of subjects: 20
Study 27848089 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention (Life-Steps) with four initial and two booster sessions delivered by nurses.
Number of subjects: 50
Study 27848089 — intervention group
Group type: COMPARATOR
Intervention: Time and session-matched comparison counseling intervention.
Number of subjects: 50
Study 26023638 — intervention group
Group type: EXPERIMENTAL
Intervention: Synergy low frictional elastomeric rings
Number of subjects: 30
Study 26023638 — intervention group
Group type: COMPARATOR
Intervention: Conventional elastomeric rings
Number of subjects: 30
Study 23381694 — intervention group
Group type: EXPERIMENTAL
Intervention: Zibotentan 10 mg once daily
Number of subjects: 1421
Study 23381694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1421
Study 21972820 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 110 mg twice daily
Number of subjects: 9522
Study 21972820 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 150 mg twice daily
Number of subjects: 9522
Study 21972820 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 75 mg twice daily (simulated for severely renally impaired patients)
Number of subjects: 9522
Study 19177542 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive quadriceps strengthening with neuromuscular electrical stimulation (NMES)
Number of subjects: 200
Study 19177542 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive quadriceps strengthening without NMES (volitional strength training)
Number of subjects: 200
Study 19177542 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (conventional rehabilitation)
Number of subjects: 200
Study 17522388 — intervention group
Group type: EXPERIMENTAL
Intervention: High HDL-C
Number of subjects: 27074
Study 17522388 — intervention group
Group type: COMPARATOR
Intervention: Low HDL-C
Number of subjects: 27074
Study 15457809 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestures during speech production
Number of subjects: 0
Study 15457809 — intervention group
Group type: COMPARATOR
Intervention: Gesture restriction
Number of subjects: 0
Study 11350844 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular gold (GST)
Number of subjects: 141
Study 11350844 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 141
Study 11350844 — intervention group
Group type: EXPERIMENTAL
Intervention: Both GST and MTX
Number of subjects: 141
Study 9394106 — intervention group
Group type: EXPERIMENTAL
Intervention: Paromomycin sulfate (3 x 1 g/day)
Number of subjects: 50
Study 9394106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 7699154 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin (800 mg i.v. OD for 4 days)
Number of subjects: 559
Study 7699154 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with teicoplanin (800 mg i.v. OD) and netilmicin (300 mg i.m. OD)
Number of subjects: 559
Study 7699154 — intervention group
Group type: COMPARATOR
Intervention: Thymostimulin (70 mg i.m. OD for the first month and every other day thereafter until discharge)
Number of subjects: 559
Study 7699154 — intervention group
Group type: COMPARATOR
Intervention: Control group (no thymostimulin)
Number of subjects: 559
Study 3582478 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 0
Study 3582478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31188232 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose reduction group (n = 17)
Number of subjects: 35
Study 31188232 — intervention group
Group type: COMPARATOR
Intervention: Dose maintenance group (n = 18)
Number of subjects: 35
Study 28294958 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 111
Study 28294958 — intervention group
Group type: COMPARATOR
Intervention: Conventional Nissen fundoplication (CNF)
Number of subjects: 111
Study 28294958 — intervention group
Group type: COMPARATOR
Intervention: CNF
Number of subjects: 111
Study 24496587 — intervention group
Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC)
Number of subjects: 100
Study 24496587 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cord clamping (ECC)
Number of subjects: 100
Study 23636032 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body medical stress reduction (MBMSR) group program for 8 weeks
Number of subjects: 43
Study 21352639 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine hydrochloride nasal spray 0.6% (OLO)
Number of subjects: 129
Study 21352639 — intervention group
Group type: COMPARATOR
Intervention: Azelastine hydrochloride nasal spray 0.1% (AZE)
Number of subjects: 129
Study 21352639 — intervention group
Group type: EXPERIMENTAL
Intervention: Both OLO and AZE
Number of subjects: 129
Study 19201696 — intervention group
Group type: EXPERIMENTAL
Intervention: tamsulosin 0.8 mg once daily (QD)
Number of subjects: 48
Study 19201696 — intervention group
Group type: EXPERIMENTAL
Intervention: alfuzosin 10 mg QD
Number of subjects: 48
Study 19201696 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 48
Study 19201696 — intervention group
Group type: EXPERIMENTAL
Intervention: tamsulosin
Number of subjects: 48
Study 19201696 — intervention group
Group type: EXPERIMENTAL
Intervention: alfuzosin
Number of subjects: 48
Study 17113722 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate (NaP)
Number of subjects: 57
Study 17113722 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 57
Study 15336247 — intervention group
Group type: EXPERIMENTAL
Intervention: Right visual field (left hemisphere) word presentation
Number of subjects: 0
Study 15336247 — intervention group
Group type: COMPARATOR
Intervention: Unconscious word reading
Number of subjects: 0
Study 15336247 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing a split-brain patient
Number of subjects: 0
Study 10895373 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day fasting
Number of subjects: 23
Study 10895373 — intervention group
Group type: COMPARATOR
Intervention: 7-day ketogenic diet
Number of subjects: 23
Study 8777471 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg + Placebo
Number of subjects: 312
Study 8777471 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg + HCTZ 6.25 mg
Number of subjects: 312
Study 8777471 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg + HCTZ 12.5 mg
Number of subjects: 312
Study 8777471 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg + HCTZ 25 mg
Number of subjects: 312
Study 1538443 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (20 micrograms/ml)
Number of subjects: 52
Study 1538443 — intervention group
Group type: COMPARATOR
Intervention: Papaverine hydrochloride (30 mg/ml)
Number of subjects: 52
Study 6520866 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger temperature biofeedback
Number of subjects: 24
Study 6520866 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontalis EMG biofeedback
Number of subjects: 24
Study 6520866 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic training
Number of subjects: 24
Study 31732303 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) applied to one ear (Group A)
Number of subjects: 60
Study 31732303 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) applied to both ears (Group B)
Number of subjects: 60
Study 31732303 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (Group C)
Number of subjects: 60
Study 30845829 — intervention group
Group type: EXPERIMENTAL
Intervention: Wristband accelerometer with activity-dependent vibration alerts
Number of subjects: 33
Study 30845829 — intervention group
Group type: COMPARATOR
Intervention: Sham wristband
Number of subjects: 33
Study 27619008 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing using only the decisional balance component (MIDB)
Number of subjects: 82
Study 27619008 — intervention group
Group type: COMPARATOR
Intervention: Health education around smoking cessation (HE)
Number of subjects: 82
Study 27619008 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MIDB and HE)
Number of subjects: 82
Study 25287585 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring
Number of subjects: 83
Study 25287585 — intervention group
Group type: EXPERIMENTAL
Intervention: Discipline
Number of subjects: 83
Study 25287585 — intervention group
Group type: EXPERIMENTAL
Intervention: Skill encouragement
Number of subjects: 83
Study 25287585 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem solving
Number of subjects: 83
Study 25287585 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother-reported monitoring
Number of subjects: 83
Study 25287585 — intervention group
Group type: EXPERIMENTAL
Intervention: Father-reported discipline
Number of subjects: 83
Study 23859475 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation intervention for resolving delirium in people with dementia
Number of subjects: 0
Study 21375745 — intervention group
Group type: EXPERIMENTAL
Intervention: Coiling
Number of subjects: 80
Study 21375745 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 80
Study 19368581 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular matrix (AM)
Number of subjects: 86
Study 19368581 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 86